All treatment interventions increased CD8+ T cell density in the tumor area, with only the Combination + anti-PD-1 group showing a significant increase compared to the Control, IL-15, and NIR-PIT groups (Fig. 4a, b left). The gene discussed is CD8A; the disease is neoplasm.